Bioventus founder
WebFeb 5, 2024 · Bioventus intends to raise $125 million in gross proceeds from an IPO of its Class A common stock, offering 7.35 million shares at a proposed midpoint price of $17.00 per share.
Bioventus founder
Did you know?
WebMar 18, 2024 · Sales Representative at Bioventus . Drew Sabol is the Sales Representative at Bioventus based in Hoofddorp, North Holland. Previously, Drew was the Personal Lines Underwriter at COUN TRY Financial and also held positions at U.S. Army Corps of Engineers, Halverson Construction Company. Read More WebGuy P. Nohra. Guy Nohra is a co-founder of Alta Partners, and was also a partner at Burr, Egan, Deleage & Co., which he joined in 1989. Nohra has been involved in the funding and development of notable medical technology and life science companies including ATS Medical, Cutera, Innerdyne, R2 Technology, deCODE genetics, and Vesica.
WebApr 10, 2024 · When is Bioventus's earnings date? Bioventus has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 9th, 2024 based off last year's report dates. Learn more on BVS's earnings history. How much revenue does Bioventus generate each year? WebJan 11, 2024 · Bioventus has a market capitalization of US$1.1b, so we would expect some institutional investors to have noticed the stock. Our analysis of the ownership of the company, below, shows that ...
WebJul 16, 2024 · Bioventus made an initial $2.5 million investment in the Agili-C IDE study in January 2024, as part of a previous financing round. ... founder & CEO, CartiHeal. “We look forward to the work ... WebApr 5, 2024 · Anthony Bihil, who retired in 2024 from the job after seven years, returns to the CEO role on an interim basis, Bioventus said. In the filing, Bioventus added that ‘Mr. Reali’s departure is ...
WebApr 4, 2024 · Bioventus ended last year with about $31.8 million in cash and $418.1 million of debt outstanding. Prior to its recent earnings call, the company announced it had amended a debt agreement with its ...
WebNov 14, 2024 · Bioventus Inc. (NASDAQ:NASDAQ:BVS) Q3 2024 Earnings Conference Call November 9, 2024 8:30 AM ETCompany ParticipantsDave Crawford - Vice … css.gov.au earning ratesWebMar 31, 2024 · Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. css goto top buttonWebFunding History. Bioventus raised a total of $116 M in funding over 2 rounds. CEO Anthony Bihl . Bioventus Executive Team & Key Decision Makers. Name & Title Social Contact Info; Keith McBride. Chief Technology Officer. Email. Phone. Reveal for Free. Alessandra Pavesio. Chief Science Officer. Email. earl fernand hootWebBioventus' adherence to high quality standards, commitment to evidence-based medicine and strong ethical behavior makes the company a trusted partner for thousands of physicians worldwide. Bioventus employs 500 … earl feeWebAug 3, 2024 · "Bioventus has a proven history of developing differentiated and market-leading technologies, and we remain committed to pursuing safe and effective best-in-class products that meet the needs of ... css gptxWebJan 24, 2024 · Bioventus is the former biologics and clinical therapies division of Smith & Nephew, a publicly traded medical equipment company based in the United Kingdom. In 2012, Bioventus spun out with financial backing from Essex Woodlands. Essex and Smith & Nephew rank as the top two largest shareholders of Bioventus, according to the filing. css go up a levelWebApr 8, 2024 · Key Insights Bioventus' significant private equity firms ownership suggests that the key decisions are influenced by shareholders from the larger public A total of 6 … css grab